AstraZeneca stock jumps after surprise lung disease trial win

AstraZeneca‘s stock rose over 3% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable shift…

Read More

Google employee charged with insider trading on Polymarket

Federal prosecutors on Wednesday charged a Google employee with insider trading at Polymarket. In a seven-page complaint filed in federal court in the Southern District of New York (SNDY), the Department of Justice (DOJ) alleges that Michele Spagnuolo, 36, a software engineer at Google, exploited her access to confidential, non-public data at Google “in the…

Read More